CALLIDITAS THERAPEUTICS AB's ticker is CALT and the CUSIP is 13124Q106. A total of 16 filers reported holding CALLIDITAS THERAPEUTICS AB in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $78,971 | -34.4% | 5,030 | +0.0% | 0.00% | – |
| Q1 2023 | $120,445 | -38.2% | 5,029 | -54.9% | 0.00% | – |
| Q4 2022 | $195,000 | +2.1% | 11,141 | -11.8% | 0.00% | – |
| Q3 2022 | $191,000 | +1093.8% | 12,625 | +1304.3% | 0.00% | – |
| Q2 2022 | $16,000 | +166.7% | 899 | +162.1% | 0.00% | – |
| Q1 2022 | $6,000 | -99.4% | 343 | -99.2% | 0.00% | -100.0% |
| Q4 2021 | $1,044,000 | +52100.0% | 42,201 | +40477.9% | 0.00% | – |
| Q3 2021 | $2,000 | – | 104 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 200,000 | $6,724,000 | 2.33% |
| BVF INC/IL | 750,000 | $25,493,000 | 1.00% |
| Logos Global Management LP | 300,000 | $10,086,000 | 0.86% |
| Vivo Capital, LLC | 311,030 | $10,457,000 | 0.47% |
| HHLR ADVISORS, LTD. | 1,047,687 | $35,611,000 | 0.28% |
| Pentwater Capital Management LP | 50,000 | $1,681,000 | 0.02% |
| Point72 Asset Management, L.P. | 102,748 | $3,454,000 | 0.02% |
| DEUTSCHE BANK AG\ | 70,236 | $2,361,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 20,484 | $696,000 | 0.00% |
| JANE STREET GROUP, LLC | 7,557 | $256,000 | 0.00% |